Covering a variety of research areas and themes, we have experts to provide media and policymakers with evidence, analysis and comment on a wide range of issues relating to the coronavirus pandemic.
Science of the virus
- Professor Andrew Beggs: Molecular genetics, focusing on colorectal, oesophageal and sarcoma cancer biology and translational medicine.
- Professor Jon Deeks: Analysis of worldwide data to examine the accuracy of SARS-CoV-2 antibody tests.
- Professor Nick Loman: Research explores the use of cutting-edge genomics and metagenomics approaches to the diagnosis, treatment and surveillance of infectious disease.
- Professor Robin May: Research centres on human infectious diseases, with a particular focus on the molecular basis of host-pathogen interactions.
- Professor Alan McNally: Microbial genomics with experience of working on H5N1 avian influenza research and surveillance, viral genomics and evolution, and experience in infectious disease epidemiology and transmission.
- Professor Gary Middleton: The tracking of cancer patients who have tested positive for COVID-19 across the UK and analyses whether COVID-19 is affected by anti-cancer treatments; UK Coronavirus Cancer Monitoring Project member.
- Professor Paul Moss: Immune responses to the virus; leading the national UK Coronavirus Immunology Consortium.
- Professor Alex Richter, Professor Adam Cunningham and Professor Mark Drayson: Developing a SARS-CoV-2 antibody test focussed on improving detection in individuals with mild COVID-19 disease.
- Dr Zania Stamataki: Viral immunologist, specialising in virus transmission, neutralising antibodies and persistent/chronic infection, particularly in the liver.
- Professor Shakila Thangaratinam: In collaboration with the World Health Organization, the analysis of how the virus affects women during and after pregnancy.
- Professor Willem van Schaik: Molecular microbiology, the human microbiome and antibiotic resistance; able to comment on epidemiology and possible public health interventions to contain/minimise the spread of coronavirus.
- Professor David Wraith: Immunology, specialising in autoimmunity and immunotherapy.
Public health
Legal and political
- Professor David H Dunn: US Politics and Foreign Policy, Trump Administration and the crisis, impact on global politics.
- Dr Alan Greene: Constitutional law, emergency powers and human rights.
- John Tingle: Health law, including issues relating to patient safety.
- Professor Karen Yeung: Data science, law and ethics, including the regulation and governance of, and through, new and emerging technologies.
Society
- Dr Brock Bersaglio: How global efforts to respond to COVID-19 are implicating and impacting wildlife trade.
- Professor John Bryson: Understanding rapid adaptation during times of disruptive and radical change. This includes responsible citizenship and citizen-led end-user innovation and the development of alternative solutions in response to private and public sector failure.
- Professor Colin Diamond: Education leadership/home-schooling during closed period.
- Professor Harry Ferguson and Dr Laura Kelly: The capacity of social workers to keep children safe during the COVID-19 pandemic.
- Dr Kayleigh Garthwaite: The challenges faced by families living on a low income during the pandemic.
- Professor Karen Guldberg: Inclusive education throughout the pandemic.
- Dr Steve Hewitt: Security issues, surveillance, terrorism anti-Americanism, UK & American politics and conspiracy theories.
- Dr Anandadeep Mandal: COVID-19 vaccine uptake and participation in vaccine trials.
- Angus McCabe and Dr Angela Ellis-Paine: How different communities are responding to the coronavirus crisis.
- Professor Jenny Phillimore: Forced migration, sexual and gender based violence during the pandemic.
- Dr Merten Reglitz: The internet as a human right, political authority, global justice and intergenerational justice.
- Dr Manbinder Sidhu: Remote home monitoring (virtual wards) during the pandemic.
- Professor Heather Widdows: The ethics behind decisions about who to put at risk and what is an acceptable risk in relation to the COVID-19 crisis.
Business and economics
Energy and transportation